
SpringWorks Therapeutics
6 open jobsBiotechnology Research
Biotechnology Research
100 Washington Blvd, Stamford, Connecticut 06902, US
201-500
2017
SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company operating in the biotechnology research industry, dedicated to improving the lives of patients with rare tumors. Founded in 2017 and headquartered at 100 Washington Blvd, Stamford, Connecticut 06902, US, the company employs more than 370 people. SpringWorks developed and commercializes the first and only FDA- and EC-approved medicine for adults with desmoid tumors, as well as the first and only FDA- and EC-approved treatment for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). The company is committed to finding the answers people with rare tumors need, driven by scientific curiosity and a sense of urgency given the importance of its mission. SpringWorks values authenticity, recognizing that diverse backgrounds, cultures, styles, and abilities strengthen its ability to deliver meaningful solutions for patients.
Based on 6 current openings

SpringWorks Therapeutics

SpringWorks Therapeutics

SpringWorks Therapeutics

SpringWorks Therapeutics

SpringWorks Therapeutics
3jobs added
Last 30 days3 jobs
Previous 30 days5 jobs
Salary range estimated from 23 job postings published on Global Work AI in the last 90 days.
$170k–$267kper year
$198,000per year